NCM·Healthcare·$170M·#112 / 520 in Healthcare
DERM Journey Medical Corporation
63SOLID
CATEGORY BREAKDOWN
GROWTH16
QUALITY64
STABILITY64
VALUATION91
GOVERNANCE100
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+10.2%
16
> 50% strong
Gross Margin
Revenue retained after direct costs
66.2%
94
> 50% strong
Cash Runway
Months of cash at current burn rate
23 months
82
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
79.7%
28
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.7x
91
< 3x strong
Rule of 40
Growth rate plus operating margin
-3
18
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
31.7%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-7.7%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE DERM WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when DERM's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.